Shares of Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) have received an average rating of "Moderate Buy" from the seven analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $51.80.
TRUP has been the topic of several analyst reports. Lake Street Capital dropped their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Stifel Nicolaus dropped their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Finally, Piper Sandler decreased their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th.
Get Our Latest Stock Analysis on Trupanion
Insider Buying and Selling
In related news, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $37.17, for a total transaction of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at $4,415,201.28. The trade was a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brenna Mcgibney sold 5,000 shares of Trupanion stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $164,950.00. Following the transaction, the insider now directly owns 3,738 shares in the company, valued at approximately $123,316.62. The trade was a 57.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,792 shares of company stock valued at $1,122,802 over the last three months. Company insiders own 5.42% of the company's stock.
Hedge Funds Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently modified their holdings of TRUP. Barclays PLC boosted its position in shares of Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock valued at $2,750,000 after purchasing an additional 47,262 shares during the period. JPMorgan Chase & Co. boosted its position in Trupanion by 2.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider's stock worth $1,189,000 after acquiring an additional 738 shares during the period. Ameritas Advisory Services LLC acquired a new stake in Trupanion during the 4th quarter worth about $389,000. Bartlett & CO. Wealth Management LLC acquired a new stake in Trupanion during the 4th quarter worth about $266,000. Finally, KBC Group NV acquired a new stake in Trupanion during the 4th quarter worth about $75,000.
Trupanion Trading Up 2.9%
Shares of NASDAQ TRUP traded up $1.34 on Tuesday, reaching $46.77. 725,875 shares of the company traded hands, compared to its average volume of 614,484. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion has a fifty-two week low of $25.90 and a fifty-two week high of $57.90. The stock has a market capitalization of $2.00 billion, a PE ratio of -203.35, a P/E/G ratio of 6.02 and a beta of 1.72. The company has a 50 day moving average of $37.96 and a 200 day moving average of $44.19.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $341.98 million during the quarter, compared to analysts' expectations of $337.81 million. During the same quarter in the prior year, the business earned ($0.16) EPS. Trupanion's quarterly revenue was up 11.7% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion will post 0.13 earnings per share for the current fiscal year.
About Trupanion
(
Get Free ReportTrupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.